Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...
STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.
Entero has signed a binding term sheet in which private biotech Journey is slated to acquire 99% of Entero’s equity, according to a Nov. 13 release. Upon completion of the proposed merger, the biotech ...
A Minnesota-based manufacturer announced its appointment of a new CEO on Tuesday. Savillex, a plastic molding manufacturer based in Eden Prairie, recently acquired a biotechnology equipment ...
Ester Baiget, CEO of biotechnology company Novonesis, and vice-chair of The B Team, is at the forefront of this ...
Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.
Edesa Biotech (EDSA) has released an update. Edesa Biotech’s CEO and Founder, Par Nijhawan, has made a strategic investment of up to $5 million in the company, demonstrating strong confidence in ...
CEO Roberto Iacone admitted in an interview that the market remains tough, even for a biotech in the red-hot ADC world. But ...
If effective, Lamassu Biotech’s innovative gene therapy could eliminate the need for surgery or chemotherapy for some types of hard-to-treat cancer, said CEO Dr. Gabi Hanna. Lamassu Biotech has ...
TORONTO - Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, has announced a new investment agreement involving its CEO, Dr. Par Nijhawan. Under the terms of the ...